ProteinQure is a Toronto-based advanced biotech company focused on the design of novel exotic peptides with broad therapeutic applications. 

To achieve this goal, the company enable the most important new therapeutic classes by allowing therapies to be delivered in a tissue-and cell-specific manner. ProteinQure use the most advanced computational tools to create novel non-viral delivery methods for the most challenging diseases.

Leveraging the unparalleled computational and predictive power of ProteinStudio™ and a deep understanding of protein structures, the company is focused on creating highly targeted, effective treatments with the potential to transform patient care and outcomes.

Greenspace was commissioned to evolve its brand strategy, mission and values to align the company for its next stage of investment and growth, reflected in a bold new brand identity and website.

ProteinQure are designing new therapeutics and drug delivery systems that will bring hope to patients with previously untreatable diseases. The company is the pioneering champion of computational peptide drug design, powered by atomic-level simulations and artificial intelligence, designing dynamic peptides that take drugs straight to their target – outperforming other treatment delivery systems. 

By daring to deliver therapeutics in a novel way ProteinQure is changing the game for drug development and bringing hope to patients with previously untreatable diseases.